SGC's high-quality proteins
The SGC has been producing high-quality proteins since 2004, focused primarily on human proteins associated with disease. Disease areas such as cancer, metabolic, inflammation, neuropsychiatry and rare diseases have been studied, with an emphasis on protein families, and many tools to enable continued research in these areas are available on the website.
High-throughput cloning and expression platforms were created in the Biotechnology Groups to enable the screening of thousands of constructs of targets in parallel. As a result of this dedicated effort, thousands of proteins were produced at a large scale for structural and functional studies.
Find our Deposited Structures